Form 4: Snowflake President of Products Sells $5.36 Million in Stock, Exercises Options
Insider Transaction Report
Snowflake Inc.'s President of Products, Benoit Dageville, executed a pre-planned sale of 25,000 shares for over $5.36 million, alongside exercising stock options and gifting shares.
Summary
- Benoit Dageville, President of Products and Director at Snowflake Inc. (SNOW), engaged in multiple transactions on July 24, 2025, under a Rule 10b5-1 trading plan adopted on March 28, 2025.
- Disposed of 5,625 shares of Common Stock as a gift.
- Exercised stock options to acquire 17,927 shares of Common Stock at an exercise price of $0.74 per share.
- Exercised stock options to acquire 7,073 shares of Common Stock at an exercise price of $13.48 per share.
- Sold 25,000 shares of Common Stock at a weighted-average price of $214.633 per share, totaling approximately $5,365,825.
- The sales price ranged from $214.510 to $215.500 per share.
- Following these transactions, direct beneficial ownership stands at 58,325 shares, which includes shares to be issued from restricted stock units.
- Indirect beneficial ownership includes 3,170,930 shares held by The Snow Trust and 750,000 shares held by The Selene GRAT No. 1, for which the Reporting Person is a trustee.
- The Reporting Person disclaims beneficial ownership of 750,000 shares held by The Thira GRAT No. 1, for which his spouse is the trustee.
Sentiment
Score: 6
Explanation: The transactions are part of a pre-arranged 10b5-1 trading plan, which mitigates concerns about opportunistic insider selling. The executive also exercised a significant number of options, indicating value realization from long-held equity. The overall picture is one of routine executive compensation management rather than a strong positive or negative signal.
Positives
- Exercised stock options at significantly lower prices ($0.74 and $13.48) compared to the current market price, indicating substantial unrealized gains on those options.
- The stock options exercised were fully vested, demonstrating the maturity of the equity compensation.
Negatives
- A significant sale of 25,000 shares by a key executive, potentially signaling a reduction in personal exposure to the company's stock.
- The gift of 5,625 shares reduces the executive's direct holdings.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale of shares by a key executive, even if pre-planned, could be perceived as a slight negative signal regarding management's conviction, though the 10b5-1 plan mitigates this. The exercise of options and continued significant indirect holdings demonstrate ongoing alignment.
Key Dates
| Date | Description |
|---|---|
| 2019-09-10 | Date of The Snow Trust UTA. |
| 2025-03-13 | Date of The Thira GRAT No. 1 and The Selene GRAT No. 1. |
| 2025-03-28 | Date the 10b5-1 trading plan was adopted by the Reporting Person. |
| 2025-07-24 | Date of the reported stock transactions (gift, option exercises, and sale). |
| 2025-07-25 | Date the Form 4 filing was signed. |
| 2027-02-07 | Expiration date for the stock option with an exercise price of $0.74. |
| 2029-12-10 | Expiration date for the stock option with an exercise price of $13.48. |
Recommendation
holdThe filing details routine insider transactions, specifically the exercise of stock options and a pre-planned sale of shares by a key executive. These actions are part of a Rule 10b5-1 trading plan, which suggests they are not based on new, material non-public information. While a sale by an executive can sometimes be a negative signal, its pre-planned nature and the context of option exercises for liquidity and diversification purposes make it a neutral event for investment decisions. The filing does not provide new information that would fundamentally alter the investment thesis for Snowflake Inc., thus a "hold" recommendation is appropriate, maintaining current positions based on broader company fundamentals and market conditions.
Keywords
Snowflake Inc., SNOW, SEC Form 4, Insider Trading, Stock Sale, Stock Options, Benoit Dageville, 10b5-1 Plan, Executive Compensation, Equity Transactions, Director, President of Products
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.